Geoffrey Hale
Fondatore presso Bioarchitech Ltd.
Profilo
Geoffrey Hale is the founder of BioAnaLab Ltd.
(founded in 2002) and Bioarchitech Ltd.
(founded in 2014).
At BioAnaLab Ltd., he held the title of Chief Executive Officer.
At Bioarchitech Ltd., he holds the title of Chief Executive Officer & Director.
Dr. Hale is also the founder of Tolerx, Inc. Currently, he is a Professor at the University of Oxford.
Previously, he was the Chairman of The Native Antigen Co. Ltd.
and a Director at Absolute Antibody Ltd.
Dr. Hale received his doctorate degree from the University of Cambridge in 1977.
Posizioni attive di Geoffrey Hale
| Società | Posizione | Inizio |
|---|---|---|
| University of Oxford | Corporate Officer/Principal | - |
Bioarchitech Ltd.
 Bioarchitech Ltd. BiotechnologyHealth Technology Bioarchitech Ltd. operates as a biotechnology company that develops oncolytic viruses for treatment of cancer. The company was founded by Kevin Maskell, Lili Wang, Geoffrey Hale, and Hannah Chen in 2014 and is headquartered in Bicester, the United Kingdom. | Fondatore | 01/01/2014 |
Precedenti posizioni note di Geoffrey Hale
| Società | Posizione | Fine |
|---|---|---|
Absolute Antibody Ltd.
 Absolute Antibody Ltd. BiotechnologyHealth Technology Absolute Antibody Ltd. provides antibody sequencing, manufacturing and engineering services. Its products include anti-allergen antibodies, anti-virus antibodies, multi-tag control protein and research grade biosimilars. The company was founded by Nicholas J. Hutchings and Neil Barclay in August 2012 and is headquartered in Oxford, the United Kingdom. | Direttore/Membro del Consiglio | 01/12/2020 |
The Native Antigen Co. Ltd.
 The Native Antigen Co. Ltd. Miscellaneous Commercial ServicesCommercial Services The Native Antigen Co. Ltd. develops viral vectors technologies. Its products include bacterial antigens, protozoal, and viral antigens. The company was founded by Nick Roesen and Andrew Maxwell in 2010 and is headquartered in Oxford, the United Kingdom. | Presidente | 01/07/2020 |
Tolerx, Inc.
 Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | Corporate Officer/Principal | - |
BioAnaLab Ltd.
 BioAnaLab Ltd. Miscellaneous Commercial ServicesCommercial Services BioAnaLab Ltd. offered biologic drug and vaccine analysis. It provided scientific and clinical insight with meticulous attention to regulatory compliance and on-time delivery. The company was founded by Stephen Cobbold, Geoff Hale and Peppy Rebello in 2002 and was headquartered in Oxford, the United Kingdom. | Amministratore Delegato | - |
Formazione di Geoffrey Hale
| University of Cambridge | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
BioAnaLab Ltd.
BioAnaLab Ltd. Miscellaneous Commercial ServicesCommercial Services BioAnaLab Ltd. offered biologic drug and vaccine analysis. It provided scientific and clinical insight with meticulous attention to regulatory compliance and on-time delivery. The company was founded by Stephen Cobbold, Geoff Hale and Peppy Rebello in 2002 and was headquartered in Oxford, the United Kingdom. | Commercial Services |
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | Health Technology |
The Native Antigen Co. Ltd.
The Native Antigen Co. Ltd. Miscellaneous Commercial ServicesCommercial Services The Native Antigen Co. Ltd. develops viral vectors technologies. Its products include bacterial antigens, protozoal, and viral antigens. The company was founded by Nick Roesen and Andrew Maxwell in 2010 and is headquartered in Oxford, the United Kingdom. | Commercial Services |
Bioarchitech Ltd.
Bioarchitech Ltd. BiotechnologyHealth Technology Bioarchitech Ltd. operates as a biotechnology company that develops oncolytic viruses for treatment of cancer. The company was founded by Kevin Maskell, Lili Wang, Geoffrey Hale, and Hannah Chen in 2014 and is headquartered in Bicester, the United Kingdom. | Health Technology |
Absolute Antibody Ltd.
Absolute Antibody Ltd. BiotechnologyHealth Technology Absolute Antibody Ltd. provides antibody sequencing, manufacturing and engineering services. Its products include anti-allergen antibodies, anti-virus antibodies, multi-tag control protein and research grade biosimilars. The company was founded by Nicholas J. Hutchings and Neil Barclay in August 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Geoffrey Hale
